Angioplasty of the popliteal artery using the Jaguar™ stent

Angioplasty of the popliteal artery using the Jaguar™ stent
复制标题

DOI:
10.5603/aa.2018.0015
复制
发表时间:
2018-01-01
期刊:
影响因子:
0.2
通讯作者:
Uryniak, Adam
Uryniak, Adam
中科院分区:
其他
文献类型:
--
作者:
Potoczny, Pawel;Janik, Piotr;Uryniak, Adam

文献摘要

被引文献

相似文献

导言。本研究的目的是根据重复狭窄/闭塞的可改变和不可改变的危险因素,根据TASC II推荐的Jaguar SM自膨式支架,评价血管内治疗动脉粥样硬化性月国动脉狭窄/闭塞的疗效。这项研究在2011-2015年间对126名男性和46名女性进行了调查,年龄在46岁到95岁之间。手术在预定和紧急模式下进行。采用Jaguar支架成形术治疗重度慢性肢体缺血和危重肢体缺血患者。评估术后月国动脉通畅性与性别、肥胖、糖尿病、吸烟和下肢动脉通畅性的关系。术后随访60个月,12个月、24个月、36个月、48个月、60个月的通畅率分别为67%、59%、53%、45%、31%。Jaguar(TM)支架植入是治疗动脉粥样硬化性动脉狭窄和闭塞的一种有效和安全的方法。在有肥胖、糖尿病和吸烟等危险因素的患者中发现了闭塞,小腿的流出动脉有限。所有患者均未发生支架断裂。
Introduction. The aim of this study was to evaluate the effectiveness of the endovascular treatment of atherosclerotic stenosis/occlusion of the popliteal artery according to TASC II recommendations using the Jaguar SM self-expanding stent depending on the modifiable and unmodifiable risk factors of repeated stenosis/occlusions.Material and methods. The study included 126 men and 46 women aged 46-95 years in 2011-2015. Surgeries were performed in the scheduled and emergency mode. Angioplasty of the popliteal artery with the Jaguar stent implantation was performed in patients with severe chronic limb ischaemia and critical limb ischaemia. Post-operative popliteal artery patency was evaluated in relation to sex, obesity, diabetes, smoking tobacco, and patency of the lower extremity arteries.Results. The postoperative patient follow-up was conducted for 60 months, demonstrating 67% patency after 12 months, 59% patency after 24 months, 53% patency after 36 months, 45% patency after 48 months, and 31% patency after 60 months.Conclusions. The Jaguar (TM) stent implantation is an effective and safe method of treatment of atherosclerotic stenosis and occlusion of the popliteal artery. The occlusion was found in patients with the risk factors such as: obesity, diabetes, and tobacco smoking, limited runoff arteries in the lower leg. Stent fracture did not occur in any patient.